Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof
AssigneeChongqing Fagen Biomedical Inc.
InventorsKai Fan, Zhiquan Zhao, Yong Chen, Chun Zhang, Lin Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeChongqing Fagen Biomedical Inc.
InventorsKai Fan, Zhiquan Zhao, Yong Chen, Chun Zhang, Lin Wang
Estimating the term…
Provided is a homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof, wherein the insulinotropic peptide analogue comprises GLP-1 and Exendin-4. The homodimer of insulinotropic peptide analogues of the invention is made by conjugating two identical insulinotropic peptide analogue molecules at the C-terminal Cys residues via disulfide bond or PEG molecule. The homodimer of insulinotropic peptide analogues of the invention has superior stability and biological activity in vivo, and prolonged half-life in the circulation, and can be used for the preparation of hypoglycemic drugs.
A homodimer of insulinotropic peptide analogues, prepared by:
A method for preparing a homodimer of insulinotropic peptide analogues, comprising:
A drug for the treatment of metabolism syndromes related to diabetes or hyperglycemia, comprising a homodimer of insulinotropic peptide analogues prepared by conjugating two identical insulinotropic peptide analogues at their C-terminal Cys residues,
Dependencies are inferred from the claim text.